Metastatic
A032001
Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study
A032002 (Suspended)
Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer (Suspended)
